Section Arrow
LMRI.NASDAQ
- Lumexa Imaging Holdings, Inc.
Quotes are at least 15-min delayed:2026/04/17 04:22 EDT
Pre Market
Last
 --
-- (--)
Bid
3.64
Ask
14
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 9.055
-0.475 (-4.98%)
Day High 
9.83 
Prev. Close
9.53 
1-M High
13.76 
Volume 
1.73M 
Bid
3.64
Ask
14
Day Low
9.03 
Open
9.52 
1-M Low
7.23 
Market Cap 
915.93M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 9.4 
20-SMA 9.81 
50-SMA 12.24 
52-W High 19.45 
52-W Low 7.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.66/--
Enterprise Value
1.84B
Balance Sheet
Book Value Per Share
6.10
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.02B
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories95.47-6.09-6.00%27.29PE
Pre Market 96.2 +0.73 +0.76%
BFLYButterfly Network5.29+0.43+8.85%-- 
Pre Market 5.28 -0.01 -0.19%
QDELQuidelOrtho Corp12.685-4.805-27.47%-- 
Pre Market 12.52 -0.165 -1.30%
BSXBoston Scientific Corp63.42-1.19-1.84%33.38PE
Pre Market 63.8808 +0.4608 +0.73%
MDTMedtronic plc85.65-1.45-1.66%24.42PE
Pre Market 86.05 +0.4 +0.47%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.